Treatment Choice and Outcomes for ESRD: Evidence From the First Year of a Nationwide Randomized Evaluation

Amy Finkelstein

Status

Completed

Conditions

End Stage Renal Disease

Treatments

Other: Payment adjustment for home dialysis and transplant

Study type

Interventional

Funder types

Other

Identifiers

NCT05005572

JPAL-9512

Details and patient eligibility

About

The investigators plan to analyze the first year of a nationwide randomized-controlled trial of end stage renal disease (ESRD) treatment choice model (ETC). This mandatory-participation program was designed by the Centers for Medicare and Medicaid Services and randomization was conducted at the hospital referral region (HRR) level. 95 HRRs were assigned to the treatment group beginning in January 2021. The investigators will study the impact of this program in the first year on treatment modality choice for ESRD and explore heterogeneity in impact across patients and providers.

Enrollment

18,621 patients

Sex

All

Ages

66+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All Medicare-certified ESRD facilities and Medicare-enrolled managing clinicians located in HRRs in the United States are required to participate.
Patient is receiving dialysis or other services for ESRD
Patient is new to dialysis, defined as not having received dialysis for at least 12 months prior to their first observed dialysis claim
Patient is enrolled in Medicare Part B

Exclusion criteria

HRRs in US territories
HRRs with 20% or more zip codes in Maryland (excluded from randomization)
Facilities and clinicians with fewer than 11 attributed beneficiaries
Patient is receiving dialysis only for an acute kidney injury
Patient is younger than 66 years of age before initiating dialysis
Patient received a kidney transplant within 12 months prior to the start of dialysis and does not have a kidney transplant failure code
Patient is enrolled in Medicare Advantage, a cost plan, or other Medicare managed care plan
Patient resides outside of the US or in one of the US territories
Patient has elected hospice
Patient has a diagnosis of dementia at any point in the first 90 days or the preceding 12 months before initiating dialysis as identified using Centers for Medicare and Medicaid Services Hierarchical condition categories (CMS-HCC)
Patient is residing in or receiving dialysis in a skilled nursing facility (SNF)